Skip to content
DraconiticResearch
Search Sources API
186,086 studies31 sourcesUpdated 57 min ago
Peer-reviewedCC BY-NC-NDAmerican journal of ophthalmology case reports

Recurrent delayed hyphema following latanoprost/netarsudil initiation in an eye with a XEN 63 gel stent: a case report.

  1. 1Institute of Ophthalmology, Santa Croce e Carle Hospital, Cuneo, Italy.
  2. 2Eye Clinic, Department of Surgical Sciences, University of Cagliari, Cagliari, Italy.

Abstract

Purpose

To describe recurrent delayed hyphema following initiation of fixed-dose latanoprost/netarsudil in an eye with a previous XEN 63 gel stent, and to discuss whether the associated IOP reduction may have unmasked a pre-existing peri-implant reflux pathway.Observations

A 72-year-old woman with advanced primary open-angle glaucoma and previous ab interno XEN 63 gel stent implantation developed recurrent spontaneous hyphema shortly after bimatoprost/timolol was replaced with latanoprost/netarsudil. Intraocular pressure decreased from 17-19 mmHg to 8-9 mmHg after treatment initiation. The first episode occurred nine days later, with blurred vision, a small anterior chamber hyphema, and fine endothelial blood deposits. Gonioscopy showed active blood reflux from tissue surrounding the proximal intracameral XEN segment, without bleeding from other angle structures. Recurrent episodes occurred despite conservative management and, subsequently, despite discontinuation of latanoprost/netarsudil. Because the peri-implant region was repeatedly identified as the reflux site, the XEN stent was eventually removed. No further bleeding episodes were observed after explantation.Conclusions and importance

The clinical course is consistent with a susceptible peri-implant anatomical configuration contributing to recurrent blood reflux. The temporal association between latanoprost/netarsudil initiation, marked IOP reduction, and the first hyphema suggests a possible precipitating or unmasking role, but does not establish drug causality. Delayed or recurrent hyphema after XEN implantation should prompt review of recent medication changes and careful gonioscopic inspection of the proximal XEN segment.

Related

  1. Real-world effectiveness and tolerability of fixed dose netarsudil/latanoprost in the management of patients with uncontrolled glaucoma
    Alessandro Siligato, Claudia Nardi, Sara Bochicchio +3
    Scientific ReportsPeer-reviewedCC BY 4.0Full textGeneral medicineCrossref
  2. Recurrent Lateral Medullary Infarction with Ipsilateral Motor and Sensory Deficits and a Delayed Worsening of Crossed Hypoalgesia and Thermohypoesthesia: A Case Report
    Yujiro Yoshioka, Takahide Nagashima, Jun Goto
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthJ-STAGE
  3. Persistent Post-Burn Pruritus Following Antihistamine Initiation: A Retrospective Longitudinal Study at a Single Italian Pediatric Burn Center
    Biagio Nicolosi, Emanuele Buccione, Felice Curcio +9
    Medical sciences (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Prevalence of Hepatitis C Infection and Treatment Initiation Following Dried Blood Spot Testing in New South Wales, Australia
    Annabelle Stevens, Anna Conway, Nigel Carrington +10
    Liver international : official journal of the International Association for the Study of the LiverPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Case Report: Delayed-onset and recurrent infectious endophthalmitis after intravitreal dexamethasone implant.
    Xinyue Yang, Mengfan Li, Yiwei Zhu +2
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{greco2026recurrent,
  title = {{Recurrent delayed hyphema following latanoprost/netarsudil initiation in an eye with a XEN 63 gel stent: a case report.}},
  author = {Antonio Greco and Valerio Calabresi and Maria Marenco and Fabio Garavelli and Giuseppe Giannaccare and Agostino Salvatore Vaiano},
  journal = {American journal of ophthalmology case reports},
  year = {2026},
  month = oct,
  doi = {10.1016/j.ajoc.2026.102680},
  url = {https://europepmc.org/article/MED/42927338},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Recurrent delayed hyphema following latanoprost/netarsudil initiation in an eye with a XEN 63 gel stent: a case report.
AU  - Antonio Greco
AU  - Valerio Calabresi
AU  - Maria Marenco
AU  - Fabio Garavelli
AU  - Giuseppe Giannaccare
AU  - Agostino Salvatore Vaiano
PY  - 2026
DA  - 2026/10/15
JO  - American journal of ophthalmology case reports
DO  - 10.1016/j.ajoc.2026.102680
UR  - https://europepmc.org/article/MED/42927338
AB  - Purpose  To describe recurrent delayed hyphema following initiation of fixed-dose latanoprost/netarsudil in an eye with a previous XEN 63 gel stent, and to discuss whether the associated IOP reduction may have unmasked a pre-existing peri-implant reflux pathway.Observations  A 72-year-old woman with advanced primary open-angle glaucoma and previous ab interno XEN 63 gel stent implantation developed recurrent spontaneous hyphema shortly after bimatoprost/timolol was replaced with latanoprost/netarsudil. Intraocular pressure decreased from 17-19 mmHg to 8-9 mmHg after treatment initiation. The first episode occurred nine days later, with blurred vision, a small anterior chamber hyphema, and fine endothelial blood deposits. Gonioscopy showed active blood reflux from tissue surrounding the proximal intracameral XEN segment, without bleeding from other angle structures. Recurrent episodes occurred despite conservative management and, subsequently, despite discontinuation of latanoprost/netarsudil. Because the peri-implant region was repeatedly identified as the reflux site, the XEN stent was eventually removed. No further bleeding episodes were observed after explantation.Conclusions and importance  The clinical course is consistent with a susceptible peri-implant anatomical configuration contributing to recurrent blood reflux. The temporal association between latanoprost/netarsudil initiation, marked IOP reduction, and the first hyphema suggests a possible precipitating or unmasking role, but does not establish drug causality. Delayed or recurrent hyphema after XEN implantation should prompt review of recent medication changes and careful gonioscopic inspection of the proximal XEN segment.
SN  - 2451-9936
ER  -